Protagenic Therapeutics, Inc.
PTIX
$0.92
-$0.11-10.32%
OTC PK
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
ACCESS Newswire
3/10/2026
-
ACCESS Newswire
1/5/2026
-
TipRanks Financial Blog
12/31/2025
-
GuruFocus
12/9/2025
-
GuruFocus
12/9/2025
-
ACCESS Newswire
11/27/2025
-
GuruFocus
11/27/2025
-
Seeking Alpha - Healthcare
11/27/2025
-
SeekingAlpha.com: All News
11/27/2025
-
GuruFocus
11/27/2025
-
ACCESS Newswire
11/14/2025
-
TipRanks Financial Blog
11/13/2025
-
GuruFocus
11/13/2025
-
GuruFocus
11/13/2025
-
The Fly
11/13/2025
-
ACCESS Newswire
10/31/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 19, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 23 and 27 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 994 8200
Address
149 Fifth Avenue
New York, NY 10010
New York, NY 10010
Country
Year Founded
Business Description
Sector
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was...
more